Graham G. Walmsley Insider Trades

Insider Trading History

Track insider trading activity for Graham G. Walmsley. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.33M 24,398 shares
$54.65
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $5.08M 93,000 shares
Last Trade
Oct 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.71M 36,832 shares
$46.49
$54.65
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $254k 24,150 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$98.5k 24,150 shares
$4.08
$10.53
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $632k 11,566 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$485k 9,398 shares
$51.61
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $65.6M 1,200,000 shares
Last Trade
Mar 27, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.18M 50,000 shares
$43.55
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $62.8M 1,150,000 shares
Last Trade
Mar 26, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.52M 58,691 shares
$43.01
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $59.6M 1,091,309 shares
Last Trade
Mar 25, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.09M 91,309 shares
$44.75
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $54.7M 1,000,000 shares
Last Trade
Jan 30, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.1M 200,000 shares
$55.36
$54.65
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $14.8M 1,408,875 shares
Last Trade
Dec 17, 2024 Sale (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.73M 700,761 shares
$6.75
$10.53
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $0 0 shares
Last Trade
Dec 17, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.73M 700,761 shares
$6.75
$10.53
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $0 0 shares
Last Trade
Dec 13, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.73M 700,761 shares
$6.75
$10.53
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $7.38M 700,761 shares
Last Trade
Dec 13, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.73M 700,761 shares
$6.75
$10.53
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $242k 23,000 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$284k 23,000 shares
$12.36
$10.53
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $1.42M 26,000 shares
Last Trade
Jun 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$599k 26,000 shares
$23.02
$54.65
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $7.46M 708,114 shares
Last Trade
Jun 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.4M 1,175,000 shares
$14.85
$10.53
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $43.7M 800,000 shares
Last Trade
Dec 08, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$993k 50,000 shares
$19.85
$54.65
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $19M 1,800,000 shares
Last Trade
Dec 05, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$655k 50,000 shares
$13.09
$10.53
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $38.3M 700,000 shares
Last Trade
Dec 01, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$850k 50,000 shares
$16.99
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $35.5M 650,000 shares
Last Trade
Nov 30, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$845k 50,000 shares
$16.90
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $21.9M 400,000 shares
Last Trade
Sep 19, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20.5M 400,000 shares
$51.34
$54.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up